Cell Therapeutics (CTIC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Therapeutics (CTIC)

CTIC 9.090

0.0%

Jun 26 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (748)	9/28/2005 9:12:14 AM
From: zeta1961	of 946

Sonus' drug, Tocosol, would be a direct competitor with Xyotax, Miller said. This piece didn't disclose that David Miller has a conflict fo interest in this case..He's bullish SNUS(it's in his 'coverage universe) and has been bearish Xyotax and Abraxane on any occassion that presents itself..seems he's the Seattle Times de facto biotech company expert.. fwiw!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next